Cremer M - Search Results

1

A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.

Kiesgen S, Liebers N, Cremer M, Arnold U, Weber T, Keller A, Herold-Mende C, Dyckhoff G, Jäger D, Kontermann RE, Arndt MA, Krauss J. Kiesgen S, et al. Among authors: cremer m. Protein Eng Des Sel. 2014 Oct;27(10):331-7. doi: 10.1093/protein/gzu040. Protein Eng Des Sel. 2014. PMID: 25301960

2

An EGF receptor targeting Ranpirnase-diabody fusion protein mediates potent antitumour activity in vitro and in vivo.

Kiesgen S, Arndt MAE, Körber C, Arnold U, Weber T, Halama N, Keller A, Bötticher B, Schlegelmilch A, Liebers N, Cremer M, Herold-Mende C, Dyckhoff G, Federspil PA, Jensen AD, Jäger D, Kontermann RE, Mier W, Krauss J. Kiesgen S, et al. Among authors: cremer m. Cancer Lett. 2015 Feb 1;357(1):364-373. doi: 10.1016/j.canlet.2014.11.054. Epub 2014 Nov 27. Cancer Lett. 2015. PMID: 25434798

3

Efficacy and toxicity of a rituximab and methotrexate based regimen (GMALL B-ALL/NHL 2002 protocol) in high risk diffuse large cell B-cell lymphoma patients as a first line treatment.

Schwarzbich MA, Schöning T, Cremer M, Lisenko K, Ho AD, Witzens-Harig M. Schwarzbich MA, et al. Among authors: cremer m. Leuk Lymphoma. 2016 Jul;57(7):1723-6. doi: 10.3109/10428194.2015.1113274. Epub 2016 Mar 16. Leuk Lymphoma. 2016. PMID: 26980422 No abstract available.

4

Cell-based immunotherapy approaches for multiple myeloma.

Kriegsmann K, Kriegsmann M, Cremer M, Schmitt M, Dreger P, Goldschmidt H, Müller-Tidow C, Hundemer M. Kriegsmann K, et al. Among authors: cremer m. Br J Cancer. 2019 Jan;120(1):38-44. doi: 10.1038/s41416-018-0346-9. Epub 2018 Dec 6. Br J Cancer. 2019. PMID: 30518815 Free PMC article. Review.

5

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

Lisenko K, Dingeldein G, Cremer M, Kriegsmann M, Ho AD, Rieger M, Witzens-Harig M. Lisenko K, et al. Among authors: cremer m. BMC Cancer. 2017 May 22;17(1):359. doi: 10.1186/s12885-017-3332-3. BMC Cancer. 2017. PMID: 28532396 Free PMC article.

6

Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.

Sauer S, Pavel P, Schmitt A, Cremer M, Kriegsmann M, Bruckner T, Jordan K, Wuchter P, Müller-Tidow C, Kriegsmann K. Sauer S, et al. Among authors: cremer m. BMC Cancer. 2020 Apr 25;20(1):353. doi: 10.1186/s12885-020-06873-7. BMC Cancer. 2020. PMID: 32334570 Free PMC article.

7

Minimal renal toxicity after Rituximab DHAP with a modified cisplatin application scheme in patients with relapsed or refractory diffuse large B-cell lymphoma.

Lisenko K, McClanahan F, Schöning T, Schwarzbich MA, Cremer M, Dittrich T, Ho AD, Witzens-Harig M. Lisenko K, et al. Among authors: cremer m. BMC Cancer. 2016 Apr 11;16:267. doi: 10.1186/s12885-016-2289-y. BMC Cancer. 2016. PMID: 27067641 Free PMC article.

8

Efficient Stem Cell Collection after Modified Cisplatin-Based Mobilization Chemotherapy in Patients with Diffuse Large B Cell Lymphoma.

Lisenko K, Cremer M, Schwarzbich MA, Kriegsmann M, Ho AD, Witzens-Harig M, Wuchter P. Lisenko K, et al. Among authors: cremer m. Biol Blood Marrow Transplant. 2016 Aug;22(8):1397-1402. doi: 10.1016/j.bbmt.2016.03.030. Epub 2016 Apr 7. Biol Blood Marrow Transplant. 2016. PMID: 27060439 Free article.

9

In Burkitt lymphoma patients who relapse after induction with a short-intensive chemoimmunotherapy protocol, aggressive salvage chemotherapy therapy is ineffective: a single-center retrospective study.

Cremer M, Schwarzbich MA, Schöning T, Lisenko K, Ho AD, Witzens-Harig M. Cremer M, et al. Ann Hematol. 2017 Sep;96(9):1573-1575. doi: 10.1007/s00277-017-3044-4. Epub 2017 Jun 16. Ann Hematol. 2017. PMID: 28623395 No abstract available.

10

Patients With Malignant Lymphoma and HIV Infection Experiencing Remission After First-Line Treatment Have an Excellent Prognosis.

Kriegsmann K, Klee JS, Hensel M, Buss EC, Kriegsmann M, Cremer M, Ho AD, Egerer G, Wuchter P, Witzens-Harig M. Kriegsmann K, et al. Among authors: cremer m. Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e581-e587. doi: 10.1016/j.clml.2019.05.019. Epub 2019 May 30. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31377211

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

564 results

Search Page

Filters